Search research articles
Contact Us
Filters
Showing results (181-190 of 204) with videos related to
Page
of 21
Sort By:
Ebiomedicine
|
September 27, 2021
The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model
Rana Abdelnabi, Caroline S Foo, Suzanne J F Kaptein, et al.
Nature Communications
|
November 13, 2023
Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson's disease mouse model
Tracy-Shi Zhang Fang, Yu Sun, Andrew C Pearce, et al.
Journal of Medicinal Chemistry
|
September 13, 2022
Developing HDAC4-Selective Protein Degraders To Investigate the Role of HDAC4 in Huntington's Disease Pathology
Natsuko Macabuag, William Esmieu, Perla Breccia, et al.
Journal of Clinical Microbiology
|
May 15, 2015
Rapid Whole-Genome Sequencing of Mycobacterium tuberculosis Isolates Directly from Clinical Samples
Amanda C Brown, Josephine M Bryant, Katja Einer-Jensen, et al.
Acta Neuropathologica Communications
|
February 13, 2025
The tumour microenvironment of pilocytic astrocytoma evolves over time via enrichment for microglia
Thomas J Stone, Jessica C Pickles, Olumide Ogunbiyi, et al.
JCO Precision Oncology
|
February 27, 2024
Cancer Risks Associated With <i>TP53</i> Pathogenic Variants: Maximum Likelihood Analysis of Extended Pedigrees for Diagnosis of First Cancers Beyond the Li-Fraumeni Syndrome Spectrum
Cristina Fortuno, Bing-Jian Feng, Courtney Carroll, et al.
Mbio
|
September 14, 2022
Immune Imprinting Drives Human Norovirus Potential for Global Spread
Lisa C Lindesmith, Florencia A T Boshier, Paul D Brewer-Jensen, et al.
Emerging Infectious Diseases
|
December 8, 2023
Emergence of Novel Norovirus GII.4 Variant
Preeti Chhabra, Damien C Tully, Janet Mans, et al.
ACS Medicinal Chemistry Letters
|
March 19, 2021
Evaluation of 5-(Trifluoromethyl)-1,2,4-oxadiazole-Based Class IIa HDAC Inhibitors for Huntington's Disease
Andrew J Stott, Michel C Maillard, Vahri Beaumont, et al.
The Journal of Infection
|
May 21, 2025
Monitoring the emergence of resistance with sotrovimab in immunocompromised patients with COVID-19: LUNAR study
Judith Breuer, Myriam Drysdale, Jill Walker, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 204) with videos related to
Sort By:
Page
of 21
Ebiomedicine
|
September 27, 2021
The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model
Rana Abdelnabi, Caroline S Foo, Suzanne J F Kaptein, et al.
Nature Communications
|
November 13, 2023
Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson's disease mouse model
Tracy-Shi Zhang Fang, Yu Sun, Andrew C Pearce, et al.
Journal of Medicinal Chemistry
|
September 13, 2022
Developing HDAC4-Selective Protein Degraders To Investigate the Role of HDAC4 in Huntington's Disease Pathology
Natsuko Macabuag, William Esmieu, Perla Breccia, et al.
Journal of Clinical Microbiology
|
May 15, 2015
Rapid Whole-Genome Sequencing of Mycobacterium tuberculosis Isolates Directly from Clinical Samples
Amanda C Brown, Josephine M Bryant, Katja Einer-Jensen, et al.
Acta Neuropathologica Communications
|
February 13, 2025
The tumour microenvironment of pilocytic astrocytoma evolves over time via enrichment for microglia
Thomas J Stone, Jessica C Pickles, Olumide Ogunbiyi, et al.
JCO Precision Oncology
|
February 27, 2024
Cancer Risks Associated With <i>TP53</i> Pathogenic Variants: Maximum Likelihood Analysis of Extended Pedigrees for Diagnosis of First Cancers Beyond the Li-Fraumeni Syndrome Spectrum
Cristina Fortuno, Bing-Jian Feng, Courtney Carroll, et al.
Mbio
|
September 14, 2022
Immune Imprinting Drives Human Norovirus Potential for Global Spread
Lisa C Lindesmith, Florencia A T Boshier, Paul D Brewer-Jensen, et al.
Emerging Infectious Diseases
|
December 8, 2023
Emergence of Novel Norovirus GII.4 Variant
Preeti Chhabra, Damien C Tully, Janet Mans, et al.
ACS Medicinal Chemistry Letters
|
March 19, 2021
Evaluation of 5-(Trifluoromethyl)-1,2,4-oxadiazole-Based Class IIa HDAC Inhibitors for Huntington's Disease
Andrew J Stott, Michel C Maillard, Vahri Beaumont, et al.
The Journal of Infection
|
May 21, 2025
Monitoring the emergence of resistance with sotrovimab in immunocompromised patients with COVID-19: LUNAR study
Judith Breuer, Myriam Drysdale, Jill Walker, et al.
Page
of 21